Augmenting in vivo exposure with fear antagonistic actions: a preliminary test
- PMID: 19187817
- DOI: 10.1016/j.beth.2007.12.006
Augmenting in vivo exposure with fear antagonistic actions: a preliminary test
Abstract
The current study investigated the efficacy of an exposure augmentation strategy in which the phobic individual is encouraged to enact actions that are in direct opposition to the fear action tendencies associated with acrophobia. Participants (N=88) meeting DSM-IV criteria for specific phobia (acrophobia) were randomized to (a) exposure with oppositional actions (E+OA), (b) exposure only (EO), (c) a credible placebo consisting of pulsed audio-photic stimulation (APS), or (d) a waitlist control (WLC). Treatment consisted of six, 6-min exposure trials. Participants were assessed with questionnaire, behavioral, and physiologic measures at pre- and posttreatment, and at a 1-month follow-up session. Participants receiving E+OA showed significantly greater improvement on behavioral and questionnaire measures than those in the other 3 conditions at both posttreatment and follow-up. Further, whereas treatment improvement generalized to an untrained context for those receiving E+OA, such was not the case for EO- and APS-treated participants. Findings suggest augmenting exposure with oppositional actions may enhance treatment outcome and thus warrant additional investigation with clinical samples.
Similar articles
-
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.Arch Gen Psychiatry. 2004 Nov;61(11):1136-44. doi: 10.1001/archpsyc.61.11.1136. Arch Gen Psychiatry. 2004. PMID: 15520361 Clinical Trial.
-
Social phobia. Longitudinal course and long-term outcome of cognitive-behavioral treatment.Psychiatr Clin North Am. 1995 Dec;18(4):821-42. Psychiatr Clin North Am. 1995. PMID: 8748383 Review.
-
A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.J Psychiatr Res. 2007 Sep;41(6):466-71. doi: 10.1016/j.jpsychires.2006.05.006. Epub 2006 Jul 10. J Psychiatr Res. 2007. PMID: 16828803 Clinical Trial.
-
Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.J Anxiety Disord. 2009 Apr;23(3):350-6. doi: 10.1016/j.janxdis.2009.01.001. Epub 2009 Jan 15. J Anxiety Disord. 2009. PMID: 19223151 Clinical Trial.
-
Specific phobias.Psychiatr Clin North Am. 2009 Sep;32(3):577-91. doi: 10.1016/j.psc.2009.05.008. Psychiatr Clin North Am. 2009. PMID: 19716991 Review.
Cited by
-
Stopping a Response When You Really Care about the Action: Considerations from a Clinical Perspective.Brain Sci. 2021 Jul 23;11(8):979. doi: 10.3390/brainsci11080979. Brain Sci. 2021. PMID: 34439598 Free PMC article. Review.
-
Control interventions in randomised trials among people with mental health disorders.Cochrane Database Syst Rev. 2022 Apr 4;4(4):MR000050. doi: 10.1002/14651858.MR000050.pub2. Cochrane Database Syst Rev. 2022. PMID: 35377466 Free PMC article.
-
The Good, the Bad, and the Ugly-Chances, Challenges, and Clinical Implications of Avoidance Research in Psychosomatic Medicine.Front Psychiatry. 2022 Feb 18;13:841734. doi: 10.3389/fpsyt.2022.841734. eCollection 2022. Front Psychiatry. 2022. PMID: 35250678 Free PMC article. Review.
-
The Effect of Augmented Reality and Virtual Reality on Inducing Anxiety for Exposure Therapy: A Comparison Using Heart Rate Variability.J Healthc Eng. 2018 Nov 25;2018:6357351. doi: 10.1155/2018/6357351. eCollection 2018. J Healthc Eng. 2018. PMID: 30595830 Free PMC article.
-
An Innovative Framework for Delivering Psychotherapy to Patients With Treatment-Resistant Posttraumatic Stress Disorder: Rationale for Interactive Motion-Assisted Therapy.Front Psychiatry. 2018 May 4;9:176. doi: 10.3389/fpsyt.2018.00176. eCollection 2018. Front Psychiatry. 2018. PMID: 29780334 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous